| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $704K | +63.7% |
| Cost of Revenue | $646K | +139.3% |
| R&D Expense | $2.7M | +14.8% |
| SG&A Expense | $4.3M | -15.3% |
| Operating Income | -$6.9M | +10.5% |
| Pre-tax Income | -$6.9M | +11.2% |
| Income Tax | $0 | — |
| Net Income | -$6.9M | +11.2% |
| EPS (Basic) | -$0.42 | +19.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -45.6% |
| Accounts Receivable | $16K | -93.1% |
| Inventory | $16K | -80.0% |
| Current Assets | $1.8M | -43.4% |
| Total Assets | $2.7M | -39.7% |
| Current Liabilities | $1.5M | +50.2% |
| Total Liabilities | $1.6M | +32.8% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.8M | +21.1% |
| Financing Cash Flow | $2.7M | -60.9% |
| $1.1M |
| -67.2% |